Hemostatic Device Malecot and Tube for Arterial Sealing

Solution Overview

Problem

Current methods for controlling blood loss after medical procedures, such as cardiac catheterizations, often rely on manual pressure, which can be inefficient and may not effectively seal arterial openings, leading to excess blood loss and potential patient trauma.

Innovation Solution

A hemostatic device comprising a first tube with a malecot and a second tube that can transition from a neutral to a stopper configuration, allowing a hemocoagulant agent to be selectively exposed to seal the puncture site, facilitating faster hemostasis and ambulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If manual pressure is used to control blood loss, then the method is simple to apply, but it is inefficient and may not effectively seal arterial openings

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The device is divided into multiple functional segments: an inner tube for vessel access, an outer tube containing the hemocoagulant agent, and a malecot for sealing. This segmentation allows each component to perform its specific function efficiently while maintaining overall system reliability for sealing arterial openings.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The hemocoagulant agent is pre-loaded into the outer tube before the procedure. When needed, the device is advanced into position and the agent is automatically delivered to the puncture site, eliminating the need for manual preparation and ensuring immediate effective sealing.

Inventive Principle:
Principle #10Preliminary action

2Loss of time

If a hemostatic device with multiple tubes and configurations is used, then hemostasis time is reduced, but the device structure becomes more complex

Engineering Contradiction:
Core Design Contradiction:
Loss of timeVSDevice complexity

Solution Approach 1:

The malecot is designed to be selectively actuatable between a neutral configuration (collapsed) and a stopper configuration (expanded). This dynamic transformation allows the device to adapt its structure during the procedure: the collapsed state minimizes profile for insertion, while the expanded state provides effective sealing against the vessel wall, reducing hemostasis time without requiring a permanently complex structure.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The inner tube is nested within the outer tube, with the hemocoagulant agent contained within the outer tube's lumen. This nested arrangement allows both tubes to be integrated in a compact configuration during storage and insertion, reducing the effective device complexity while enabling sequential deployment: the inner tube is advanced first, then the outer tube is positioned to deliver the agent, achieving rapid hemostasis.

Inventive Principle:
Principle #7Nested doll (Nesting)

3Ease of operation

If the hemocoagulant agent is retained in the device, then controlled delivery is achieved, but the device requires additional mechanisms for agent exposure

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The device utilizes the natural blood flow and pressure differential to automatically deliver the hemocoagulant agent. When the outer tube is positioned at the puncture site and the malecot is expanded, the agent is passively extruded through the tube wall or opening by blood flow pressure, eliminating the need for complex active delivery mechanisms such as pumps or valves, while maintaining controlled delivery.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The outer tube serves as an intermediary structure that contains and protects the hemocoagulant agent during insertion and positioning. The tube wall or controlled opening acts as the interface between the contained agent and the blood flow, allowing selective exposure of the agent to the puncture site without requiring complex delivery mechanisms.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device effectively reduces the time required for hemostasis and ambulation by sealing the arterial opening with a hemocoagulant agent, providing a more controlled and efficient method compared to manual pressure.

Implementation Method 1

retaining a hemocoagulant agent in the second lumen... selectively orienting the second tube such that the hemocoagulant agent is at least partially exposed... sealing the puncture of a vessel

Methodology Applied
Scientific EffectCoagulation: Coagulation

Data Source

PatentUS10722226B2Hemostatic device and its methods of use
Publication Date: 2020.07.28
  • US10722226B2 patent drawing
  • US10722226B2 patent drawing
  • US10722226B2 patent drawing

AI summary

A hemostatic device for sealing a puncture of a vessel includes a first tube defining a first lumen, and a malecot coupled to the first tube. The malecot is selectively actuatable from a neutral configuration to a stopper configuration. The hemostatic device also includes a second tube circumscribing at least a portion of the first tube. The second tube at least partially defines a second lumen and a third lumen. The second tube includes a first opening in flow communication with the third lumen and positioned proximally relative to the malecot. The second tube is selectively orientable to at least partially expose a hemocoagulant agent retained in the second lumen.